A novel method for quantification of globotriaocylceramide (GL-3) inclusions in affected podocytes in females with Fabry disease shows progressive accumulation of GL-3 in podocytes with age and no cross-correction between affected and non-affected podocytes

Najafian Behzad; Sokolovskiy Alexey; Mauer Michael

首页> 外文期刊>Molecular genetics and metabolism >A novel method for quantification of globotriaocylceramide (GL-3) inclusions in affected podocytes in females with Fabry disease shows progressive accumulation of GL-3 in podocytes with age and no cross-correction between affected and non-affected podocytes

【24h】

A novel method for quantification of globotriaocylceramide (GL-3) inclusions in affected podocytes in females with Fabry disease shows progressive accumulation of GL-3 in podocytes with age and no cross-correction between affected and non-affected podocytes

机译：一种新的用于量化的植物中的球蛋白（GL-3）夹杂物的雌性在雌性疾病中的患者中含有（GL-3）夹杂物，表明，随着年龄和受影响和非受影响的大织物之间的跨校正，GL-3的逐渐积累

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Molecular genetics and metabolism》 |2019年第2期|共1页
作者
Najafian Behzad; Sokolovskiy Alexey; Mauer Michael;
展开▼
作者单位

Univ Washington Seattle WA 98195 USA;

Univ Washington Seattle WA 98195 USA;

Univ Minnesota Minneapolis MN USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
专利

1. A novel method for quantification of globotriaocylceramide (GL-3) inclusions in affected podocytes in females with Fabry disease shows progressive accumulation of GL-3 in podocytes with age and no cross-correction between affected and non-affected podocytes [J] . Najafian Behzad, Sokolovskiy Alexey, Mauer Michael Molecular genetics and metabolism . 2019,第2期

机译：一种新的用于量化的植物中的球蛋白（GL-3）夹杂物的雌性在雌性疾病中的患者中含有（GL-3）夹杂物，表明，随着年龄和受影响和非受影响的大织物之间的跨校正，GL-3的逐渐积累
2. Podocyte globotriaosylceramide (GL-3) content strongly impacts age-dependent podocyte loss in ERT-naive male Fabry patients [J] . Najafian Behzad, Tondel Camilla, Svarstad Einar, Molecular genetics and metabolism . 2017,第1a2期

机译：Podocyte Globotriaosyla酰胺（GL-3）含量强烈影响ERT-Naive雄性法布里患者的年龄依赖性泛细胞损失
3. Podocyte globotriaosylceramide (GL-3) content in female adult patients with Fabry disease and amenable mutations reduces following 6 months of treatment with migalastat [J] . Molecular genetics and metabolism . 2020,第2期

机译：雌性成年患者的Podocyte GlObotriaosylaCide（GL-3）含量患者患有Magalastat的6个月治疗后减少6个月
4. Podocyte Injury and GL-3 Accumulation are Progressive in Young Patients with Fabry Disease [O] . Behzad Najafian, Einar Svarstad, Leif Bostad, -1

机译：足细胞损伤和GL-3积累是渐进的年轻患者与法布瑞氏症
5. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease [O] . Najafian Behzad, Svarstad Einar, Bostad Leif, 2011

机译：青年法布里病患者进行性足细胞损伤和球囊糖基神经酰胺（GL-3）积累

A novel method for quantification of globotriaocylceramide (GL-3) inclusions in affected podocytes in females with Fabry disease shows progressive accumulation of GL-3 in podocytes with age and no cross-correction between affected and non-affected podocytes

著录项

相似文献

相关主题

期刊订阅